Monte Carlo-energy minimization of correolide in the Kv1.3 channel: possible role of potassium ion in ligand-receptor interactions
暂无分享,去创建一个
[1] E. Campbell,et al. Crystal Structure of a Mammalian Voltage-Dependent Shaker Family K+ Channel , 2005, Science.
[2] M. Karplus,et al. Effective energy function for proteins in solution , 1999, Proteins.
[3] V. Ananthanarayanan,et al. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists. , 2001, Archives of biochemistry and biophysics.
[4] B. Zhorov,et al. KvAP-based model of the pore region of shaker potassium channel is consistent with cadmium- and ligand-binding experiments. , 2005, Biophysical journal.
[5] P. Bradley,et al. Toward High-Resolution de Novo Structure Prediction for Small Proteins , 2005, Science.
[6] R. Aldrich,et al. A Mutation in S6 of Shaker Potassium Channels Decreases the K+ Affinity of an Ion Binding Site Revealing Ion–Ion Interactions in the Pore , 1998, The Journal of general physiology.
[7] V. Ananthanarayanan. Peptide hormones, neurotransmitters, and drugs as Ca2+ ionophores: implications for signal transduction. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[8] W. Welsh,et al. Structural Model Reveals Key Interactions in the Assembly of the Pregnane X Receptor/Corepressor Complex , 2006, Molecular Pharmacology.
[9] F. Ashcroft,et al. Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State , 2003, Science.
[10] K. Takano. ON SOLUTION OF , 1983 .
[11] B. Zhorov,et al. Potassium, sodium, calcium and glutamate‐gated channels: pore architecture and ligand action , 2004, Journal of neurochemistry.
[12] G. Kaczorowski,et al. Binding of Correolide to the Kv1.3 Potassium Channel: Characterization of the Binding Domain by Site-Directed Mutagenesis† , 2001 .
[13] P. Focia,et al. Structural basis of TEA blockade in a model potassium channel , 2005, Nature Structural &Molecular Biology.
[14] O. Hensens,et al. Potent nor-triterpenoid blockers of the voltage-gated potassium channel Kv1.3 from Spachea correae , 1998 .
[15] O. Hensens,et al. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3. , 1999, Biochemistry.
[16] J. Liu,et al. Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affinity interaction. , 1999, The Journal of biological chemistry.
[17] V. Ananthanarayanan,et al. Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand. , 1996, Biophysical journal.
[18] G. Yellen,et al. Intracellular gate opening in Shaker K+ channels defined by high-affinity metal bridges , 2004, Nature.
[19] P. Kollman,et al. An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.
[20] Youxing Jiang,et al. Crystal structure and mechanism of a calcium-gated potassium channel , 2002, Nature.
[21] G. Kaczorowski,et al. Potent Kv1.3 inhibitors from correolide-modification of the C18 position. , 2005, Bioorganic & medicinal chemistry letters.
[22] G. Yellen,et al. The Activation Gate of a Voltage-Gated K+ Channel Can Be Trapped in the Open State by an Intersubunit Metal Bridge , 1998, Neuron.
[23] P. Bregestovski,et al. Chloride channels of glycine and GABA receptors with blockers: Monte Carlo minimization and structure-activity relationships. , 2000, Biophysical journal.
[24] Yi Liu,et al. Blocker protection in the pore of a voltage-gated K+ channel and its structural implications , 2000, Nature.
[25] B. Zhorov,et al. Atomic determinants of state‐dependent block of sodium channels by charged local anesthetics and benzocaine , 2006, FEBS letters.
[26] B. Zhorov,et al. Sodium channel activators: Model of binding inside the pore and a possible mechanism of action , 2005, FEBS Letters.
[27] R. MacKinnon,et al. The occupancy of ions in the K+ selectivity filter: charge balance and coupling of ion binding to a protein conformational change underlie high conduction rates. , 2003, Journal of molecular biology.
[28] G. Kaczorowski,et al. Pharmacology of voltage-gated and calcium-activated potassium channels. , 1999, Current opinion in chemical biology.
[29] R. MacKinnon,et al. Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors , 2001, Nature.
[30] S. Grissmer,et al. Interaction of d-Tubocurarine with Potassium Channels: Molecular Modeling and Ligand Binding , 2006, Molecular Pharmacology.
[31] J. Matkó. K+ channels and T-cell synapses: the molecular background for efficient immunomodulation is shaping up. , 2003, Trends in pharmacological sciences.
[32] H. Scheraga,et al. Monte Carlo-minimization approach to the multiple-minima problem in protein folding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[33] G. Kaczorowski,et al. Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis. , 2001, Biochemistry.
[34] J. Ruppersberg. Ion Channels in Excitable Membranes , 1996 .
[35] O. McManus,et al. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. , 1999, Cellular immunology.
[36] Eamonn F. Healy,et al. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .
[37] Jane Mitchell,et al. How Batrachotoxin Modifies the Sodium Channel Permeation Pathway: Computer Modeling and Site-Directed Mutagenesis , 2006, Molecular Pharmacology.
[38] M. Cadene,et al. X-ray structure of a voltage-dependent K+ channel , 2003, Nature.
[39] B. Chait,et al. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.